PDSNGL™B from probiotics and it’s a Next-Generation, Bioactive DNA derived from safe probiotic strains, designed to deliver the regenerative power of highly purified polynucleotides in a stable, ready-to-use form.
PRODUCT INFORMATION |
|
|
Structural / Composition Data |
|
Structure / Formula |
Polydeoxyribonucleotide; linear polymer of 2'-deoxyribonucleotides |
Molecular Weight |
~50 - 500 kDa (Controlled fragment size distribution) |
Appearance |
Liquid |
Purity |
98% |
Solubility |
Soluble in aqueous buffers (PBS, saline, sterile water) |
Form(s) Available |
Liquid for research use |
Stability & Shelf Life |
|
Storage |
24 months at -20 °C; 12 months at 2–8 °C (protected from light) |
Post-Reconstitution |
Stable for 24 hours at 2–8 °C; for long-term storage, aliquot and store at -20 °C |
Stability Notes |
Protect from light. Avoid repeated freeze-thaw cycles. |
Quality & Compliance |
|
QC Tests |
Endotoxin (<0.1 EU/mg), Sterility, DNA Concentration, Absence of host cell proteins |
Intended Use |
For research and pharmaceutical development use only |
Documentation |
Available on request |
|
|
General Guidance |
Reconstitute with sterile, endotoxin-free water or buffer to desired concentration (e.g., 10-50 mg/mL). Gently mix by swirling. Do not vortex. |
Recommendations |
For cell culture applications, filter sterilize through 0.22µm filter before use. |
|
|
Mechanism of Action |
Binds to and activates Adenosine A2A Receptor (A2AR). Provides nucleotide precursors for tissue repair. Promotes cellular proliferation and migration through purinergic signaling pathways. |
Biological Claims |
• Tissue regeneration and wound healing • Anti-inflammatory effects • Angiogenesis promotion • Fibroblast proliferation and collagen synthesis |
|
|
Intended Uses |
• Cell culture media supplement • Wound healing research • Tissue engineering scaffolds • Pharmaceutical intermediate • Skincare formulation research |
|
|||
Sizes Per vail |
1000 PPM / vials |
5000 PPM / vials |
10000 PPM / vials |